» Authors » Gabriele Hessling

Gabriele Hessling

Explore the profile of Gabriele Hessling including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 104
Citations 900
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lengauer S, Erhard N, Popa M, Telishevska M, Krafft H, Bahlke F, et al.
J Cardiovasc Electrophysiol . 2025 Jan; 36(3):625-631. PMID: 39853802
Introduction: Data regarding safety and long-term outcome of very high-power-short duration (vHPSD) ablation in adult congenital heart disease (ACHD) patients with paroxysmal or persistent atrial fibrillation (AF) are lacking. Methods:...
2.
Erhard N, Bahlke F, Neuner B, Popa M, Krafft H, Tunsch-Martinez A, et al.
Sci Rep . 2024 Oct; 14(1):25370. PMID: 39455654
The question of optimal timing for catheter ablation of atrial fibrillation (AF) to achieve best outcomes remains a crucial clinical issue. As AF occurs less frequently in younger patients, data...
3.
Erhard N, Englert F, Prommersberger S, Popa M, Bourier F, Reents T, et al.
Heart Rhythm . 2024 Jul; 22(1):57-64. PMID: 39019385
Background: Pulsed field ablation (PFA) has become increasingly important in the treatment of cardiac arrhythmias. In addition to single-shot devices mainly used for pulmonary vein isolation, focal PFA may provide...
4.
Lennerz C, OConnor M, Schaarschmidt C, Reents T, Bourier F, Telishevska M, et al.
J Interv Card Electrophysiol . 2024 May; PMID: 38775921
Background: Pulse field ablation (PFA) is a novel catheter ablation technology with potential safety benefits due to its tissue selectivity. It has the potential to directly damage or interact with...
5.
Bahlke F, Wachter A, Erhard N, Englert F, Syvari J, Krafft H, et al.
Pacing Clin Electrophysiol . 2024 May; 47(8):994-1003. PMID: 38728067
Background: Lesion durability and transmurality are crucial for successful radiofrequency (RF) ablation. This study provides a model of real-time RF lesion visualization and insights into the role of underlying parameters,...
6.
7.
Bahlke F, Englert F, Popa M, Bourier F, Reents T, Lennerz C, et al.
J Cardiovasc Electrophysiol . 2024 Jan; 35(3):406-414. PMID: 38197476
Introduction: Despite advanced ablation strategies and major technological improvements, treatment of persistent atrial fibrillation (AF) remains challenging and the underlying pathophysiology is not fully understood. This study analyzed the multiple...
8.
Popa M, Bahlke F, Kottmaier M, Foerschner L, Bourier F, Lengauer S, et al.
J Cardiovasc Electrophysiol . 2023 Dec; 35(2):317-327. PMID: 38105426
Introduction: Pulmonary vein isolation (PVI) using radiofrequency ablation (RFA) is an established treatment strategy for atrial fibrillation (AF). To improve PVI efficacy and safety, high-power short-duration (HPSD) ablation and pulsed-field...
9.
Telishevska M, Lengauer S, Reents T, Kantenwein V, Popa M, Bahlke F, et al.
J Clin Med . 2023 Oct; 12(20). PMID: 37892670
Background: The aim of this study was to assess long-term efficacy and safety of empirical slow pathway (ESP) ablation in pediatric and adult patients with a special interest in patients...
10.
Bahlke F, Wachter A, Erhard N, Englert F, Krafft H, Popa M, et al.
Pacing Clin Electrophysiol . 2023 Aug; 46(10):1170-1181. PMID: 37616376
Background: The influence of power, duration and contact force (CF) on radiofrequency (RF) lesion formation is well known, whereas data on local impedance (LI) and electrode-tissue-coverage (ETC) is scarce. The...